Current treatment is inadequate
Current treatment is usually hypocaloric diet, medications,
and aerobic exercise recommendation. However, current
pharmacological treatment of type 2 diabetes focuses on
management of the resulting hyperglycemia, hypertension,
dyslipidemia andatherosclerosis, yet does not address the
underlying causes leading to insulin resistance: visceral obesity
and physical inactivity. Paradoxically, insulin and some oral
hypoglycemics cause significant weight gain. Additionally, older
obese adults find weight loss diets are notoriously difficult to